Rankings · Growth
Fastest-growing A-graded companies
Graded A, with more than $1B of revenue now and at least $250M three years ago, ranked by how fast revenue grew each year over those three years — the same comparison the grade’s own “revenue growing overall” check makes.
65 companies meet this test
Figures as of September 30, 2026
| # | Company | Grade | Revenue growth | Free cash flow growth | Net margin | Market value |
|---|---|---|---|---|---|---|
| 1 | NVSNovartis AG | A | +70% a year | +10% a year | -0.1% | $278B |
| 2 | HIMSHIMS & HERS HEALTH, INC. | A- | +54% a year | — | -5.5% | $6.6B |
| 3 | ALNYALNYLAM PHARMACEUTICALS, INC. | A+ | +53% a year | — | 19.7% | $34B |
| 4 | ONCBEONE MEDICINES LTD. | A+ | +50% a year | — | 10.7% | $41.6B |
| 5 | OSCROscar Health, Inc. | A | +46% a year | +206% a year | 3.6% | $9.9B |
| 6 | GMEDGLOBUS MEDICAL, INC. | A+ | +42% a year | +84% a year | 17.0% | $10.2B |
| 7 | ALHCALIGNMENT HEALTHCARE, INC. | A | +41% a year | — | 0.9% | $1.6B |
| 8 | LLYELI LILLY AND COMPANY | A+ | +39% a year | +70% a year | 33.5% | $1.12T |
| 9 | PACSPACS Group, Inc. | A | +32% a year | — | 4.8% | $6.7B |
| 10 | HALOHALOZYME THERAPEUTICS, INC. | A+ | +29% a year | +40% a year | 24.9% | $12.7B |
More rankings
A ranking orders companies by one stated measure. It is not a recommendation, and it says nothing about whether any share price is reasonable.